Amarillo Biosciences Inc (OTCMKTS:AMAR)’s stock price was up 11.5% on Friday . The company traded as high as $0.30 and last traded at $0.20, approximately 16,104 shares traded hands during trading. An increase of 229% from the average daily volume of 4,896 shares. The stock had previously closed at $0.18.
The business has a 50-day simple moving average of $0.23 and a two-hundred day simple moving average of $0.25.
Amarillo Biosciences (OTCMKTS:AMAR) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.01) earnings per share (EPS) for the quarter. Amarillo Biosciences had a negative return on equity of 885.22% and a negative net margin of 6,736.02%. The company had revenue of $0.02 million for the quarter.
About Amarillo Biosciences (OTCMKTS:AMAR)
Amarillo Biosciences, Inc engages in the development of biologics for the treatment of human and animal diseases. The company owns or licenses five issued patents related to the low-dose oral delivery of interferon; and owns one issued patent on its dietary supplement, Maxisal. It focuses on research for the treatment of human disease indications primarily influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha.
Recommended Story: What does a bar chart mean for investors?
Receive News & Ratings for Amarillo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarillo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.